Other ASH Meetings

Other ASH Meetings

Highlights and interviews from the American Society of Hematology’s meetings

On location

Inotuzumab Ozogamicin Plus Low-Intensity Chemotherapy Is Safe, Effective in Older Patients With ALL

In February 2017, the U.S. Food and Drug Administration granted inotuzumab ozogamicin priority review for the treatment of adult patients with relapsed/refractory B-cell precursor...
On location

Harnessing the Power of Gene Editing

For years, scientists have been manipulating genes in animal and human cells to gain a better understanding of how genomes work, with an eye...

ASH Sickle Cell Disease Summit: A Call to Action

In mid-April, more than 60 experts in sickle cell disease (SCD), including clinicians and researchers, federal agency partners, representatives from industry, and other members...
Advertisement

Current Issue

October 2020 Volume 6, Issue 12

This issue examines racism in the U.S. health care system, discusses the FDA's newly loosened blood donation restrictions, and more.

Block title